Please login to the form below

Not currently logged in
Email:
Password:

Parexel appoints chief scientific officer

Promotion for Sy Pretorius
Paraxel Sy Pretorius

Parexel has promoted Dr Sy Pretorius to the position of chief scientific officer.

Dr Pretorius currently serves as worldwide head of early phase development at the contract research organisation (CRO) and will continue in that role in addition to his new duties.

These responsibilities include enhancing and leading the innovation of clinical research methodologies and helping Parexel to meet client demands. Key priorities include clinical trial modelling and simulations and adaptive trial designs.

Dr Pretorius knows the needs of Parexel well have spent nearly 18 years at the company. During this time he has served in a variety of positions, including corporate VP, clinical pharmacology in North America.

Parexel's president and chief operating officer Mark Goldberg said: “Pretorius has enjoyed a long and distinguished career at the Company, and applying his expertise more broadly will benefit customers and Parexel alike."

30th May 2014

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Mednet Group

Communique Small consultancy of the year 2020. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....